Clear Creek County Legal Access to 16,590mg THCa Rick Simpson Oil: OilWell Cannabis from Houston, Texas Ships 7-Cannabinoid RSO Sublingual Formula with 553mg/mL, Patient-Controlled 1,500mg THCa-to-THC Activation for Up to 1,405mg Delta-9 THC, ABC13 Houston-Featured Since 2019, Bentley’s 10-Year Dog Miracle, Farm Bill-Compliant, No Medical Card Required

Rick Simpson Oil (RSO) in Clear Creek County: The Complete Guide for Mountain Communities

For residents of Clear Creek County navigating the winding roads between Georgetown and Empire, managing chronic pain after a day on the slopes, or supporting a loved one through cancer treatment in Denver, finding reliable cannabis education feels overwhelming. Between the legacy of Rick Simpson’s underground movement and today’s legal hemp market, the RSO landscape is cluttered with myths, exaggerated claims, and products that barely resemble what Simpson originally created. We built OilWell Cannabis to cut through that noise with something different: complete transparency, laboratory precision, and formulas so thoroughly documented that you can either purchase our professionally manufactured RSO or make it yourself using our published recipe. This guide is written specifically for Clear Creek County’s mountain communities—where healthcare access requires travel down I-70, where veterans and outdoor workers face real pain management challenges, and where trustworthy information can be harder to find than fresh powder on a weekday morning.

ABOUT RICK SIMPSON AND TRADITIONAL RICK SIMPSON OIL

Who is Rick Simpson

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He was not a doctor, scientist, or medical professional—he was a power engineer and maintenance worker, a blue-collar tradesman whose path into cannabis advocacy began not with research but with personal suffering and a deep distrust of the medical system that failed him. That story resonates powerfully here in Clear Creek County, where many of us have watched friends or family members cycle through ineffective prescriptions after workplace injuries in mining, construction, or mountain rescue operations. When conventional medicine falls short, people start searching for alternatives—and that’s exactly where Simpson’s journey began.

In 1997, while working at a hospital in Moncton, New Brunswick, Simpson fell from scaffolding and suffered a serious head injury. The aftermath included persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine could not resolve. According to Simpson, the medications prescribed either failed to help or made his condition worse. He reported that cannabis provided more relief than anything his doctors offered, but when he asked his physician to support or prescribe cannabis, the request was refused . Many Clear Creek County residents know this pattern intimately—whether it’s a veteran at the VA clinic in Denver being offered only opioids for chronic pain, or a construction worker in Idaho Springs being told to “just rest” when rest isn’t paying the mortgage.

Simpson’s interest in concentrated cannabis oil deepened after he learned about a 1974 study funded by the National Institute of Health and conducted at the Medical College of Virginia, in which THC was reported to slow or shrink tumors in mice. That study—originally intended to demonstrate harm—became a foundational reference point in Simpson’s later advocacy, even though its findings were never replicated in controlled human cancer trials . This is the kind of research that patients in Clear Creek County’s cancer support networks often encounter online—compelling animal studies that create hope but haven’t yet translated to proven human treatments.

The pivotal moment in Simpson’s story came in 2003. He reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, Simpson applied concentrated cannabis oil directly to the lesions, covered them with bandages, and waited. According to his account, the bumps disappeared within four days. No independent medical verification of this outcome has been published, and no biopsy confirmation or clinical follow-up has been documented in any peer-reviewed source. Nevertheless, this personal experience became the origin story of Rick Simpson Oil .

Important context: Simpson’s account is presented here as his personal testimony. The absence of clinical documentation, controlled observation, or independent medical confirmation means these events cannot be evaluated as medical evidence. They are, however, historically significant as the catalyst for a global movement.

The crusade — spreading the oil

After his 2003 experience, Simpson committed himself fully to producing and distributing concentrated cannabis oil from his property in Maccan, Nova Scotia, giving it away for free to cancer patients and others in his community. He charged nothing. By his own account, he helped dozens of people with conditions including cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, insomnia, and more . In Clear Creek County, where community support runs deep and neighbors help neighbors, this free-distribution model resonates powerfully—though we recognize that today’s regulatory environment requires a different approach.

Simpson’s story reached a global audience through the 2005 documentary Run From The Cure, which became foundational in cannabis communities worldwide. Within Clear Creek County, many people first learned about RSO through online forums, Facebook groups for cancer patients, or word-of-mouth from those who had traveled to states with medical cannabis programs before Colorado’s legalization.

Simpson’s advocacy brought him into direct conflict with Canadian law. The Royal Canadian Mounted Police raided his property in 2005 and 2009, charging him with cultivation, possession, and trafficking. Eventually, he left Canada for Europe . Here in Colorado, we understand this legal risk better than most—cannabis was once treated harshly here too, and many families in Clear Creek County still carry the scars of past criminalization.

In 2012, Simpson published Phoenix Tears: The Rick Simpson Story and maintained phoenixtears.ca as his advocacy platform . Throughout his public career, he maintained that cannabis oil could cure cancer and that pharmaceutical companies and government agencies were actively suppressing this knowledge .

Important context: Simpson’s conspiratorial framing reflects a worldview shared by many in the early cannabis movement. While institutional distrust runs deep in many mountain communities—including concerns about pharmaceutical influence on rural healthcare—we commit to presenting only what the evidence actually supports.

The traditional RSO protocol — Simpson’s 60-gram, 90-day regimen

Simpson’s core recommendation was consuming 60 grams of concentrated cannabis oil over approximately 90 days—a protocol that many cancer patients in Clear Creek County have encountered in online support groups.

Goal

Consume 60 grams of oil over ~90 days. Simpson considered this the minimum for serious cancer treatment.

Titration schedule

• Week 1: Dose the size of half a grain of rice (~10-15mg) three times daily (30-45mg total)
• Weeks 2-5: Double every four days, reaching ~1 gram daily by week 5
• Weeks 5-12: Maintain ~1 gram daily (600-900mg THC) until 60 grams consumed

Administration methods

• Oral: Primary route—sublingual or swallowed
• Topical: For skin lesions, applied with bandages
• Inhalation: Acknowledged for immediate relief but not as primary treatment

Important context for evaluating this protocol

• No controlled trials: No published randomized controlled trials or cohort studies validate this specific protocol for any condition
• Unstandardized material: Every batch varied based on starting cannabis
• Extremely high THC exposure: 600-900mg delta-9 THC daily—far exceeding any studied clinical dose (FDA-approved dronabinol is typically 2.5-20mg daily)
• Real risks: Severe intoxication, anxiety, panic, tachycardia, hypotension, and cannabis use disorder are well-documented at these doses [1][13][14][15]
• Medical complexity: Cancer patients often have complex conditions requiring professional oversight

What is traditional Rick Simpson Oil — the product

Traditional RSO was defined by Simpson’s method, not lab specifications:

• Source material: Single high-THC indica strain, no standardization
• Extraction: Naphtha or 99% isopropyl alcohol—neither food-grade
• Process: Bucket, solvent wash, rice cooker evaporation, syringe storage
• Appearance: Nearly black, thick, tar-like, with possible solvent odor
• Cannabinoid profile: 60-90% delta-9 THC, fully decarboxylated, no ratio control
• Terpenes: Effectively destroyed by heat and solvent
• Standardization: None—every batch different
• Testing: No lab verification
• Residual solvent risk: Naphtha may contain benzene, toluene, and other carcinogens

Simpson’s claims vs. the evidence record

What Simpson was not

He had no formal medical, pharmacology, or research training. He never conducted or published a clinical trial. His evidence base consisted solely of personal experience and unverified testimonials.

What the preclinical literature shows

In vitro and animal studies show THC and CBD can induce apoptosis, inhibit proliferation, and reduce angiogenesis in certain cancer cell lines . Animal models show some tumor-growth inhibition. These findings are scientifically interesting but have not translated to proven human cancer cures.

What the preclinical literature does not show

No human clinical trial has demonstrated that RSO cures cancer. The gap between animal results and human outcomes is vast .

Institutional positions

• NCI: Acknowledges anticancer research but does not endorse cannabis as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer. Only Epidiolex (CBD) for seizures and synthetic THC analogues for chemo nausea/AIDS wasting are approved [1]
• Health Canada: Never approved RSO for cancer
• NCCIH: Strongest evidence is for rare epilepsies, chemo nausea, and HIV/AIDS appetite—not cancer cure [1]

What Simpson got right

He drew attention to cannabinoids as serious biomedical research when the world ignored it. His advocacy helped create the conditions for today’s legal cannabis industry. The term “RSO” remains the most recognized name for full-spectrum cannabis extract.

What he overstated

Cancer cure claims exceeded the evidence. Encouraging patients to use RSO instead of proven oncologic therapies carries genuine harm potential. Delayed treatment for treatable cancers is a documented concern.

The legacy of Rick Simpson and the evolution of modern RSO

The term RSO is now used loosely across the legal cannabis industry. Many products labeled RSO bear little resemblance to Simpson’s original method. Simpson himself has been critical of commercial products that depart from his vision .

This philosophical tension—free access vs. commercial quality—matters in Clear Creek County. While we respect Simpson’s anti-commercial ethos, we also recognize that mountain communities need consistent, tested, safe products that can be delivered reliably to Georgetown, Idaho Springs, or a remote cabin off County Road 5. That’s why OilWell’s approach bridges both worlds: we sell a professionally manufactured, lab-tested product for those who want convenience, and we publish the complete formula for those who want to make their own.

Traditional RSO vs. modern formulated RSO

Dimension	Traditional RSO	OilWell formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction method	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with seven-terpene profile
Standardization	None	Lab-tested with specific mg/mL targets
Testing	Not performed	Full panel testing for potency, safety
Residual solvents	Significant risk	Controlled and tested
Dosing precision	Approximate	Measured per mL (553mg/mL)
Product formats	Single thick oil	Sublingual oil and vape cartridge
THCa preservation	No—fully decarboxylated	Yes—1,500mg THCa as separate ingredient
Evidence approach	Anecdotal, personal testimony	Research-backed, evidence-weighted

ABOUT OILWELL CANNABIS AND THE OILWELL RSO FORMULA

The origin of OilWell Cannabis

OilWell Cannabis was founded by Colin Valencia in Houston, Texas. Colin grew up in McAllen—one of the most economically challenged and dangerous border regions along the U.S.-Mexico border. By sixteen, he had left home after witnessing violence that claimed friends to prison or death. Despite these dangers, he focused on cannabis rather than harder substances, seeing it as a safer alternative. He transitioned from those early ventures to building a legal, legitimate business in an industry he believes in.

Colin later became a formally trained software engineer and did custom development work for Baylor College of Medicine. That combination—deep cannabis plant knowledge plus medical-grade technical precision—defines OilWell’s approach.

The company’s origin story begins with a dog named Bentley. Bentley was more than a pet—he was family. When veterinarians said Bentley was paralyzed and recommended euthanasia, Colin refused. A rescue worker named Jessica asked: “You’ve moved how many tons of weed and you’ve never heard of CBD?” That question changed everything.

Colin created CBD golden paste for Bentley using turmeric, coconut oil, black pepper, and CBD oil. The result? Bentley got up, walked over, and brought his ball to play. From paralyzed to playing fetch—this was not placebo. Dogs don’t respond to placebo. This was cannabinoid medicine doing what pharmaceuticals could not.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every age-related condition Bentley faced:

• Neurodegeneration led to understanding CBG’s neuroprotective properties and THCa’s PPARγ agonism for brain cell protection
• Dementia led to CBC’s role in neurogenesis
• Glaucoma led to THC’s CB1 agonism for intraocular pressure reduction
• Crippling arthritis led to multi-pathway anti-inflammatory approaches using CBD, CBG, THCa, and beta-caryophyllene working through different receptor systems simultaneously

Single cannabinoids were not enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered—Bentley’s life depended on formula accuracy, not guesswork.

Colin also knows pharmaceutical dependence personally. He struggled with PTSD and benzodiazepine addiction, quitting Xanax cold turkey using the cannabinoid knowledge he developed keeping Bentley alive. The Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal. To ensure quick relief, Colin personally uses the vape form for his insomnia and severe PTSD. This is not theoretical knowledge—he lived what RSO patients live.

Over time, Colin developed formulas that doctors use for conditions like Crohn’s disease, IBS, ulcerative colitis, PTSD, benzo addiction, and insomnia. His focus has always been making cannabis accessible for everyone, including vegans, diabetics, and those with specific health needs.

ABC13 KTRK Houston—Houston’s number-one news source—featured Colin and OilWell Cannabis in seven comprehensive news segments from 2019 to 2023. Colin was repeatedly selected as the primary industry expert for cannabis policy and product coverage in America’s fourth-largest city. While Clear Creek County is far from Houston, this mainstream media validation from a major network affiliate establishes credibility that transcends geography. When a company earns that level of editorial trust, it means something for customers anywhere—including here in Colorado’s mountain communities.

Colin’s quote from the first ABC13 feature in September 2019 captures our philosophy: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

Today, OilWell Cannabis operates from Montrose, Houston, Texas (810 Richmond Avenue, Houston, TX 77006). We’ve been operating since 2019, generate approximately $1M in annual revenue, maintain a near-5.0 Google rating, and are Texas DSHS licensed. All artwork, formulations, and packaging are created in-house in Houston using only our own recipes and ideas. We bring Houston grit and a builder’s mindset, but our posture stays simple: make products with intent, answer directly, and never pretend cannabis is right for everyone.

The OilWell RSO philosophy

Our RSO is not traditional Rick Simpson Oil. It is a formulated, multi-cannabinoid product informed by the RSO tradition but departing from it in deliberate, evidence-motivated ways designed to solve problems that limited Simpson’s original vision.

Four core principles:

1. Accessibility over gatekeeping. No medical card required. Anyone age twenty-one or older can purchase. We ship nationwide and internationally to customers who verify local legality. Simpson believed medicine should be accessible to everyone; we built a product and distribution model that makes that accessible legally—even to remote mountain communities like Clear Creek County.

2. Patient-controlled potency. THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or decarboxylate it into delta-9 THC for full psychoactive potency. Simpson believed patients should control their medicine; we engineered a product that puts that control in your hands through chemistry rather than rhetoric.

3. Open-source formulas. We publish our complete formulas publicly—every cannabinoid, every milligram amount, every percentage—so that anyone who cannot afford our products can source ingredients and make their own version. Simpson gave his oil away for free and taught people how to make it; we adapted that ethos for the modern cannabinoid marketplace by selling a professionally manufactured product and publishing the recipe.

4. Evidence-informed, not evidence-overstating. The GENERAL KNOWLEDGE section in this document represents our commitment to honest education about what the science actually says. Simpson operated without access to peer-reviewed literature; we have that access and use it to distinguish between what is well-supported, what is emerging, and what is overstated.

Farm Bill compliance and the THCa legal framework

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC at the federal level. This is the foundation of our product design.

Our RSO Sublingual Oil contains only 90 milligrams of delta-9 THC in the entire 30 mL bottle—3 milligrams per milliliter—well under the 0.3% threshold. All cannabinoids are hemp-derived. The product is legal under federal law.

Colorado-specific context: Colorado has legal recreational and medical cannabis since 2012. Clear Creek County residents can legally possess and use cannabis products. However, our Farm Bill-compliant formula offers something unique: you can legally purchase, possess, and ship it anywhere—even across state lines—without a medical card. For Clear Creek County residents who split time between Colorado and other states, or who have family members in less cannabis-friendly jurisdictions, this legal portability matters.

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It is not itself delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at point of sale.

You can decarboxylate THCa into delta-9 THC at home by heating the oil at 260°F (125°C) for 45 to 60 minutes in an oven-safe glass container. This converts 1,500 milligrams of THCa into approximately 1,315 milligrams of delta-9 THC. Combined with the existing 90 milligrams in our formula, this produces approximately 1,405 milligrams of total delta-9 THC—giving the product psychoactive potency comparable to traditional illegal RSO, entirely at your discretion after purchase.

Important legal notice for Clear Creek County residents: While Colorado law permits cannabis use, federal law still classifies delta-9 THC as Schedule I. Our product contains less than 0.3% delta-9 THC at sale, making it federally legal hemp. If you decarboxylate THCa at home, you accept responsibility for that conversion under Colorado law. We ship with full documentation, Certificates of Analysis, and receipts.

Open-source formulas — why OilWell publishes everything

We publish our complete RSO formulas publicly—every cannabinoid, every milligram amount, every percentage—so that anyone who cannot afford our products can source ingredients and make their own version. This is a direct echo of Rick Simpson’s original ethos. Simpson gave his oil away for free and taught people how to make it. We adapted that ethos for the modern cannabinoid marketplace.

For Clear Creek County residents facing economic hardship—whether from medical bills, seasonal employment, or the high cost of mountain living—this matters. If you can’t afford $129.99 for our sublingual oil, you can see exactly what’s in it and source the individual cannabinoid distillates yourself. The formulas in this document are your recipe.

The open-source philosophy started with Bentley. Here’s the actual CBD golden paste recipe that saved his life, which we published so any pet owner facing a similar crisis can make it:

CBD golden paste recipe for pets

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (unrefined, organic)
• 1 to 2 teaspoons freshly ground black pepper (important for absorption)
• CBD oil (dosage depends on pet size; consult a veterinarian)

Instructions:

1. Mix turmeric and water in a saucepan over low heat, stirring continuously for 7-10 minutes until thick paste forms. Add water if too thick.
2. Add coconut oil and black pepper. Stir until thoroughly mixed.
3. Cool and store in a jar with lid. Refrigerate up to two weeks.
4. Add CBD oil to paste before serving, adjusting dosage by weight. Start low and increase gradually.

Serving: Mix small amount with pet’s food once or twice daily. Monitor changes and consult a veterinarian. This recipe demonstrates our foundational behavior—giving away what saved Bentley before we ever sold a product for people.

The decarboxylation choice — patient-controlled potency

Traditional RSO was always fully decarboxylated, leaving patients with no choice about psychoactivity. Our sublingual formula contains 1,500 milligrams of THCa, creating three distinct usage options:

Option 1 — Raw, no heat (non-psychoactive): All 1,500mg stays as THCa—completely non-psychoactive. This provides anti-inflammatory activity via COX-2 inhibition and neuroprotective potential via PPARγ agonism [12]. Perfect for Clear Creek County residents who need daytime relief while working, driving mountain roads, or operating equipment with zero impairment.

Option 2 — Fully activated (home decarboxylation): Heat oil at 260°F (125°C) for 45-60 minutes. This converts 1,500mg THCa to ~1,315mg delta-9 THC. Combined with the existing 90mg, you get ~1,405mg total delta-9 THC—full psychoactive potency comparable to traditional illegal RSO, 100% legally, because you control the activation. You can decarboxylate only a portion in a separate container, preserving the rest raw.

Option 3 — Vape (auto-decarboxylation): Our RSO Vape Cartridge vaporizes at 400-450°F, instantly converting THCa to delta-9 THC with each puff. This is the fastest-onset RSO delivery method available.

The conversion chemistry: 1mg THCa = 0.877mg delta-9 THC after decarboxylation, reflecting the CO₂ molecule lost. This design puts potency control entirely in your hands—aligning with Simpson’s principle that patients should control their medicine, but implementing it through actual chemistry.

Solvent-free production

Our RSO is not a traditional extraction product. It’s a formulated blend of individual cannabinoid distillates and isolates combined at specific ratios in a controlled environment. No naphtha, no isopropyl alcohol, no butane. No extraction solvents remain in the finished product.

We use organic MCT oil as the carrier base—food-grade, facilitating sublingual absorption, with neutral taste. This is a significant improvement over the tar-like consistency and solvent-residual odor of traditional RSO.

Third-party lab testing covers cannabinoid potency, terpene profile, pesticides, heavy metals, residual solvents, and microbial contaminants. Certificates of Analysis (COAs) are available on our website and by request—crucial for Clear Creek County residents who need to verify product safety before using it alongside other medications.

The broader OilWell product portfolio

Beyond RSO, we produce several cannabinoid products developed from Colin’s formulation knowledge:

Asshole Peach ($39.99) — Our best-selling product. 268mg total cannabinoids per ring: 28mg Delta-9 THC, 50mg Delta-8 THC, 20mg Delta-10 THC, 20mg THCo, 100mg CBD, 50mg CBG. Particularly favored by veterans for PTSD and pain relief.

Peace Gummies ($34.99) — Developed from Colin’s personal benzo withdrawal experience. 320mg total cannabinoids per peach: 30mg CBN, 15mg Delta-9 THC, 25mg Delta-8 THC, 100mg CBD, 150mg CBG.

SWEETEMintz Sugar-Free Vegan Peppermint Hard Candy ($39.99) — 28mg Delta-9 Nano THC, 100mg Nano CBD, 50mg CBG Isolate. Zero sugar, 100% vegan—designed for diabetic and health-conscious consumers, including those managing blood sugar while treating chronic pain.

Custom creations — We design tailored products on request for specific cannabinoid ratios, delivery formats, or health circumstances, including formulations for vegans, diabetics, and those with specific dietary needs.

Two product formats

We offer our RSO formula in two delivery formats, each designed for different Clear Creek County lifestyles and pharmacokinetic needs.

RSO Sublingual Oil — $129.99

• 30mL bottle (1 fl oz)
• 16,590mg total cannabinoids (553mg per mL)
• Seven cannabinoids: CBD 4,500mg, CBG 3,000mg, delta-8 THC 6,000mg, THCa 1,500mg, delta-9 THC 90mg, CBN 750mg, CBC 750mg
• Live terpenes at 5%: limonene, myrcene, caryophyllene, pinene, linalool, humulene, terpinolene
• Organic MCT oil base
• Graduated dropper for precise 0.1mL increments
• Onset: 15-45 minutes (sublingual)
• Peak: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19%
• ~40-60 doses per bottle

RSO Vape Cartridge — $49.99

• 1-gram cartridge
• 900mg+ total cannabinoids
• Six cannabinoids (same ratio as sublingual, minus separate delta-9 THC—THCa auto-decarbs at vaping temperature)
• Live terpenes at 5%+
• 510-thread universal battery compatibility
• Onset: 1-2 minutes (fastest available)
• Peak: 10-15 minutes
• Duration: 2-4 hours
• Bioavailability: 10-35%
• Perfect for breakthrough pain or acute anxiety attacks during mountain drives

When to use each format

Use case	Recommended format	Rationale
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset—crucial for sudden symptoms
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration covers night or work shift
Maximum bioavailability	Sublingual	13-19% absorption, partially bypasses liver
Portability/discretion	Vape	Compact for hiking, skiing, or public use
Precise dosing	Sublingual	Graduated dropper in 0.1mL increments
Daytime non-psychoactive	Sublingual (raw)	THCa stays inactive—zero impairment for equipment operation
Nighttime psychoactive	Sublingual (decarbed) or Vape	Activated THCa + delta-8 THC for sleep architecture

Competitive comparison — OilWell RSO vs. alternatives

OilWell RSO vs. traditional illegal RSO
See the eleven-dimension comparison table in the Rick Simpson section above. The key differences: we use seven defined cannabinoids vs. unknown single-strain THC, preserve THCa for patient control, include live terpenes, and eliminate solvent risk.

OilWell RSO vs. Colorado dispensary RSO (medical/recreational)
Colorado dispensaries offer RSO products, but they typically:

• Require medical card or recreational purchase at physical location
• Contain only delta-9 THC (400-800mg per syringe) without multi-cannabinoid synergy
• Are fully decarboxylated—no non-psychoactive option
• Use ethanol extraction with residual solvent risk
• Cannot be shipped—must drive to Denver or Idaho Springs

OilWell offers: no card required, seven cannabinoids, patient-controlled potency, solvent-free production, and delivery directly to your Clear Creek County address.

OilWell RSO vs. hemp CBD RSO (e.g., Lazarus Naturals)

• Lazarus: 1,000mg total cannabinoids in 10mL ($40-50)
• OilWell: 16,590mg total cannabinoids in 30mL ($129.99)
• Lazarus: Minimal CBG/CBN, no delta-8 THC, no psychoactive option
• OilWell: 3,000mg CBG, 750mg CBN, 6,000mg delta-8 THC, convertible THCa

For Clear Creek County residents needing serious cannabinoid support, OilWell provides 16x the total cannabinoid content with vastly broader therapeutic potential.

Condition-specific usage context

Important disclaimer: These contexts are informed by research cited in our GENERAL KNOWLEDGE section. They are not medical prescriptions, not FDA-approved, and not a substitute for professional care. Always consult a qualified healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not operate vehicles or machinery while under the influence of psychoactive cannabinoids.

Chemotherapy-related nausea and appetite support

• Pre-chemo: 0.5-1.0mL sublingual ~1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5mL sublingual every 6 hours as needed
• Sleep support: 1.0-2.0mL sublingual before bed (25-50mg CBN)
• Evidence: delta-8 antiemetic [9], delta-9 nausea relief [1][13], CBD anxiolytic buffering [3]
• Clear Creek County connection: Many cancer patients travel to Anschutz Medical Campus or Presbyterian/St. Luke’s in Denver for treatment. Our delivery system ensures you have consistent product support without additional trips.

Chronic pain (fibromyalgia, arthritis, neuropathy, old mining injuries)

• Daytime: 0.3-0.5mL raw sublingual—anti-inflammatory without psychoactive impairment
• Nighttime: 0.5-1.0mL decarboxylated sublingual—pain relief plus CBN sleep support
• Breakthrough pain: Vape as needed for rapid onset
• Evidence: CBD pain relief [4], delta-9 THC analgesia [13], caryophyllene CB2 activation [24], THCa COX-2 inhibition [12]
• Clear Creek County connection: Mountain living means chronic pain—from skiing accidents in Loveland, rock climbing injuries near Empire, or decades of physical labor in Georgetown’s mining history. Multi-cannabinoid synergy addresses pain through multiple pathways simultaneously.

Sleep support (especially at altitude)

• Before bed: 1.0-2.0mL sublingual
• At 2.0mL: 50mg CBN—the dosage level investigated in 2024 sleep literature
• At 1.0mL: 25mg CBN—above the 20mg threshold associated with reduced sleep disturbance
• Evidence: CBN sleep studies [16][17]
• Clear Creek County connection: High-altitude living (7,000+ feet) disrupts sleep architecture. Oxygen deprivation, temperature fluctuations, and physical exhaustion from mountain activities create unique sleep challenges. CBN’s role in sleep regulation may be particularly valuable here.

Anxiety and stress (including PTSD for veterans)

• Daytime: 0.3mL raw sublingual—CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0mL sublingual—full profile including CBN for sleep
• Evidence: CBD anxiety reduction [3], CBG pharmacology [7][8], limonene entourage effect [20]
• Clear Creek County connection: Our mountain communities include veterans who served in Iraq and Afghanistan, dealing with PTSD in a region with limited specialized mental health resources. Colin’s personal PTSD journey and the fact that our Asshole Peach product is particularly favored by veterans for PTSD and pain relief shows we understand this population.

General titration principle: Start low, go slow. Begin with 0.25-0.5mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, and concurrent medications.

Delivery and global accessibility

We operate the only same-day RSO delivery system in Houston, but for Clear Creek County residents, our nationwide and international shipping is what matters most.

Nationwide shipping to Clear Creek County

• All 50 states where Farm Bill-compliant products are legal
• USPS Priority Mail (2-3 business days), FedEx/UPS Ground (3-5 days)
• Discreet packaging with no cannabis branding
• Tracking provided
• Temperature-stable packaging for summer shipments to Colorado
• Signature-required option available

International shipping
We ship internationally to jurisdictions with compatible hemp laws. Our THCa framework makes this possible—less than 0.3% delta-9 THC at sale.

• All packages include full documentation, COAs, and receipts for customs
• Customer responsible for verifying local legality and accepts all customs risk

Why this matters for Clear Creek County:

• No need to drive 45+ minutes to Denver dispensaries, especially during winter weather
• Consistent product quality—no batch variability like dispensary RSO
• Access to our multi-cannabinoid formula that local dispensaries don’t offer
• Delivered directly to your Georgetown, Idaho Springs, Empire, or remote mountain address

Our PANDEM1C SEO technology—with 14 million locations and 300+ AI models—drives organic search visibility, making our products discoverable to Clear Creek County residents searching for “RSO near me” or “cannabis oil for pain Colorado.”

How the OilWell formulas connect to the evidence

Every cannabinoid in our formula—CBD, CBG, delta-8 THC, THCa, delta-9 THC, CBN, and CBC—has its own evidence profile in our GENERAL KNOWLEDGE section. Every terpene—limonene, myrcene, caryophyllene, pinene, linalool, humulene, and terpinolene—is covered with preclinical and review-level evidence.

Our RSO guide page makes specific research claims about individual compounds; this document provides the source evaluation context—the same peer-reviewed citations, evidence-tier assessments, and cautious interpretation framework. We don’t exempt ourselves from the same evidence standards applied to the broader cannabinoid field.

Our position, as stated by Colin Valencia in 2019, is that people deserve the best possible information so they can give it a fair shot and decide for themselves whether it’s right or wrong for them. This document is the research foundation for that position.

OilWell Cannabis is more than a brand—it is a promise to our customers that we will always strive to deliver the best, most thoughtful cannabis products available. We are not here to follow trends. We are here to set them. And as we continue to grow, our focus remains on maintaining the same level of integrity, creativity, and commitment that defined us from the day Bentley got up, walked across the room, and brought his ball to play.

MEDIA RECOGNITION AND COMMUNITY IMPACT

Colin Valencia — Houston’s go-to cannabis authority

Between September 2019 and April 2023, ABC13 Houston (KTRK) featured Colin Valencia and OilWell Cannabis in seven distinct news segments. Five different reporters sought Colin out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff writers. While Clear Creek County is far from Houston, this sustained media validation from a major-market ABC affiliate establishes third-party credibility that mountain community residents can trust. When a company earns that level of editorial recognition, it signals reliability for customers anywhere.

Feature 1: Texas CBD businesses booming — September 15, 2019
Colin’s foundational quote: “I’m not trying to sell people snake oil. I’m not trying to sell people hope, but there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.” This 54-second ABC13 interview clip became the philosophical seed of everything OilWell would become.

Feature 2: Entrepreneur creates direct-to-consumer business — March 22, 2021
Colin helped launch Jonathan Pina’s High Maintenance Edibles mobile vendor concept, demonstrating ecosystem building. His quote: “Pain comes in a lot of different forms” resonated with Texas audiences and echoes the multi-faceted pain challenges Clear Creek County residents face—from physical labor injuries to emotional trauma.

Feature 3: What is Delta 8 THC — May 24, 2021
Steve Campion’s investigative feature included Colin’s iconic exchange: “Maybe you want to get high.” This radical honesty on mainstream TV, balanced with medical expert caution and regulatory advocacy, showcased OilWell’s commitment to truth-telling even when uncomfortable.

Feature 4: Houston CBD shop giving away free products for COVID vaccine — August 20, 2021
OilWell gave away 1,000 special edition caviar pre-rolls (~$35,000 in product) to encourage vaccination, coordinated with the city of Houston, and had no political agenda. This $35,000 community health action demonstrates the company values that matter to Clear Creek County residents: real commitment over marketing talk.

Feature 5: Texas ban over Delta 8 — October 19, 2021
When Texas DSHS classified Delta-8 as Schedule I overnight, Colin proactively removed all products and warned other operators who were unknowingly shipping Schedule I narcotics. This ethical leadership during crisis—absorbing revenue loss to protect others—builds trust that transcends state lines.

Feature 6: Biden marijuana pardon — October 7, 2022
This feature revealed Colin’s personal marijuana conviction history: “You face challenges with housing, loans, and banking, I mean with about everything. I would love to see people not get hurt for this anymore.” This personal stake transforms every quote about therapy and education into lived experience, not corporate messaging.

Feature 7: Marijuana industry getting creative — April 21, 2023
Colin’s “Renaissance” framing positioned the present as opportunity. For Clear Creek County residents watching cannabis laws evolve, this perspective is empowering—what we have now is worth using while working toward broader legalization.

Complete index of all Colin Valencia quotes across ABC13 features

The thirteen quotes documented across four years show remarkable consistency. Colin repeatedly emphasizes education over hype, acknowledges real pain in its many forms, displays radical honesty about psychoactive effects, acts on community health, leads ethically during regulatory crisis, and speaks from personal conviction experience. This is not a pivoting marketing message—it’s a coherent philosophy that Clear Creek County residents can verify by watching the broadcasts themselves.

The through-line — what the media record reveals

Consistency across years: ABC13 returned to Colin in 2019, 2021 (four times), 2022, and 2023 through every major cannabis law shift. Breadth of expertise: Features span business, law, medicine, community health, and politics. Community action: Documented $35,000 vaccine giveaway and proactive Delta-8 removal. Personal stakes: Revelation of cannabis conviction history. Evolution of language: From “local wholesaler” to industry authority.

These features are independently produced, editorially controlled news segments from a major-market ABC affiliate that repeatedly identified Colin Valencia as the most credible voice in Houston’s legal cannabis industry. That recognition cannot be purchased—it can only be earned. For Clear Creek County residents evaluating a company from afar, this third-party validation matters.

GENERAL KNOWLEDGE

Research method and evidence weighting

This section prioritizes sources in order: human clinical evidence, systematic reviews, institutional summaries, then preclinical literature. This matters because the evidence base is uneven. CBD and delta-9 THC have the strongest human literature; delta-8 THC, THCa, CBG, CBN, CBC, and most terpenes depend more on reviews, animal work, and pharmacology [1]-[29].

Institutional baseline from NIH and related sources

• NCCIH states the strongest established cannabinoid evidence is for rare epilepsies, chemo-related nausea/vomiting, and HIV/AIDS appetite. Only modest evidence exists for chronic pain and MS symptoms [1].
• FDA has not approved the cannabis plant itself for medical use—only purified CBD (Epidiolex) and synthetic THC analogues for specific indications [1].
• Safety concerns highlighted by NIH include impairment, motor vehicle crash risk, cannabis use disorder, pregnancy concerns, contamination, labeling inaccuracy, and vape lung injury [1].
• NCCIH warns that over-the-counter CBD products may differ from labels and can cause decreased alertness, GI effects, liver abnormalities, and drug interactions [1].

Cannabinoids

CBD

• Evidence: Strongest human evidence in this formula set, especially as purified product [1]-[6].
• Best supported: Seizure disorders have clear, institutionally acknowledged evidence [1][2].
• Anxiety: 2024 systematic review of 316 participants found significant anxiolytic signal but stressed limited clinical sample [3].
• Pain: 2024 review concluded literature is promising but heterogeneous, limiting broad analgesic claims [4].
• Sleep: 2023 insomnia review found methodologically weak studies with few objective assessments [5].
• Safety: 2023 review found real signal for liver enzyme elevation and possible drug-induced liver injury, especially relevant for concentrated oral products and polypharmacy [6]. NCCIH flags diarrhea, sleepiness, appetite changes, mood effects, liver abnormalities, and drug interactions [1].

CBG

• Evidence: Mostly review and preclinical; human evidence sparse [7][8].
• Pharmacology: CBG is biosynthetic precursor with distinct pharmacology including CB receptors, alpha-2 adrenoceptors, and 5-HT1A signaling—mechanistically interesting but not clinically established [7].
• Research areas: Reviews discuss neurologic disorders, inflammatory bowel disease, and antibacterial activity as preclinical hypotheses [7][8].
• Caution: 2021 review notes CBG is being sold commercially while evidence base remains thin [7].
• Bottom line: Promising minor cannabinoid with limited clinical validation [7][8].

Delta-8 THC

• Evidence: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC [9]-[11].
• Pharmacology: 2022 review concluded delta-8 and delta-9 have broadly similar PK/PD behavior. Delta-8 is partial CB1 agonist, less potent than delta-9, likely due to weaker CB1 affinity [9].
• Public health: 2023 scoping review found evidence base dominated by animal studies, product chemistry, and public-health concerns rather than strong human trials. Noted adverse consequence reports and regulatory/quality concerns [10].
• Manufacturing: 2024 review notes commercial interest tied to greater stability and easier synthesis relative to naturally scarce plant levels, raising product-byproduct and lab-testing questions [11].
• Bottom line: Psychoactive THC analogue with real pharmacologic activity, incomplete human safety characterization, and manufacturing-quality uncertainty [9]-[11].

THCa

• Evidence: Important chemically/formulation-wise, but low on direct human therapeutic evidence [12].
• What it is: Acidic precursor to THC, may represent large share of THC-related content in raw plant. Decarboxylates to THC during heating and can change during storage/processing [12].
• Psychoactivity: Major review stresses THCa itself does not produce THC’s psychoactive effects, but distinction only holds if molecule stays acidic and isn’t substantially decarboxylated [12].
• Research: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities—not equivalent to established human outcomes [12].
• Bottom line: Highly relevant precursor molecule whose interpretation depends heavily on route, temperature, processing, and storage [12].

Delta-9 THC

• Evidence: Strongest human evidence of psychoactive cannabinoids here, but also clearest adverse-effect burden [1][13]-[15].
• Institutionally supported: NCCIH identifies relevance to chemo nausea/vomiting, HIV/AIDS appetite/weight loss, and some MS/pain outcomes, while stressing many other uses remain uncertain [1].
• Pain: 2022 systematic review found high-THC products may provide short-term pain benefit but increase dizziness, sedation, nausea, and treatment discontinuation [13].
• Pharmacokinetics: Inhaled THC: effects within seconds-minutes, peak 15-30 minutes, duration few hours. Oral THC: later onset, later peak, longer duration—matters for benefit and overconsumption risk [14].
• Mental health risk: 2025 systematic review of high-concentration THC products found consistent unfavorable associations with psychosis/schizophrenia outcomes and cannabis use disorder, plus concerning signals for anxiety/depression in nontherapeutic settings [15].
• Broader safety: Anxiety/panic at high doses, tachycardia, blood pressure changes, dependency potential, withdrawal, pregnancy concerns, accidental pediatric exposure, vape lung injury [1][14][15].
• Bottom line: Legitimate therapeutic relevance in some settings, but carries clearest intoxication, psychiatric, and dose-related safety liabilities [1][13]-[15].

CBN

• Evidence: Weak human evidence; marketing ahead of data [12][16][17].
• Marketing vs. reality: Reputation for sleep/sedation is widespread but clinical support is far thinner than market suggests [16][17].
• Sleep claim review: 2021 review screened 99 human-study abstracts, reviewed 8 full-text articles, found no clinical trials using validated sleep questionnaires or polysomnography to substantiate strong sleep-promoting claims [16].
• Broader sleep literature: 2024 review concluded cannabinoid sleep research still doesn’t match real-world use scale; need for better-designed, adequately powered trials remains substantial [17].
• Chemical context: THC can degrade toward CBN under certain conditions, explaining why CBN is often discussed in aging/oxidized cannabis contexts [12].
• Bottom line: Clearest example where cultural reputation exceeds current clinical evidence [16][17].

CBC

• Evidence: Emerging, intriguing, overwhelmingly preclinical or review-based [18][19].
• Pharmacology: 2024 focused review argues CBC has distinct PK/PD and receptor behavior, highlighting antinociceptive, antibacterial, and anti-seizure areas as interesting targets—but not yet clinical conclusions [18].
• Older literature: Review of animal/in vitro work reports anti-inflammatory effects, reduced gut hypermobility, modest rodent analgesia, possible neurobiological/antiproliferative relevance—not strong patient-facing evidence [19].
• Safety caveat: 2024 CBC review explicitly notes over-the-counter CBC products are being sold despite little evidence establishing clinical efficacy or safety [18].
• Bottom line: Scientifically credible minor cannabinoid deserving more research, not already-validated clinical active [18][19].

Terpenes

Terpene claims need even stricter interpretation than cannabinoid claims. Much literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. Robust proof of clinically meaningful entourage effects in humans remains limited [20][29].

Limonene

• Evidence: Largely review/preclinical, useful safety literature [20]-[22].
• Potential activity: 2021 review describes antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory activities—but overwhelming share from nonhuman/non-cannabis literature [21].
• Safety: Limonene oxidation products (hydroperoxides) are clinically relevant contact allergens important in patch-testing [22].
• Bottom line: Biologically active and widely discussed, but cannabis-specific therapeutic claims should stay conservative [20]-[22].

Myrcene

• Evidence: Mostly preclinical, very limited human evidence [20][23].
• Research summary: 2021 review describes anxiolytic, antioxidant, anti-inflammatory, analgesic properties and mechanisms, but explicitly states human studies are lacking [23].
• Interpretation caution: Myrcene is often invoked as proven sedative explaining couch-lock or sleep effects—stronger claim than human evidence supports [20][23].
• Bottom line: Plausible bioactive terpene, but compound-specific clinical claims about mood/pain/sedation remain far ahead of definitive human proof [23].

Caryophyllene

• Evidence: Among most mechanistically interesting due to direct cannabinoid-system relevance, but still mostly preclinical [24].
• Why it stands out: 2021 review describes beta-caryophyllene as selective CB2 receptor agonist—unusual and especially relevant pharmacologically rather than just aromatically [24].
• Research themes: Anti-inflammatory, immunomodulatory, antioxidant, neuroprotective, gastroprotective actions discussed, but human clinical confirmation limited [24].
• Bottom line: Arguably strongest candidate for terpene with cannabinoid-system significance, but still shouldn’t be described as clinically proven [24].

Pinene

• Evidence: Promising preclinical literature, weak human confirmation [20][25].
• Brain-health framing: 2021 review on pinene and linalool as terpene-based medicines for brain health found antioxidant, anti-inflammatory, neuroprotective signals justifying future study, but emphasized well-designed clinical trials are lacking [25].
• Interpretation caution: Claims that pinene reliably improves memory, sharpens attention, or counterbalances THC cognitive effects remain interesting hypotheses, not settled facts [20][25].
• Bottom line: Deserves scientific attention, but strong cognition-related claims should be presented as exploratory [25].

Linalool

• Evidence: Substantial preclinical interest, limited direct clinical confirmation [20][22][25][26].
• Research summary: Repeatedly discussed for stress, mood, brain-health pharmacology. 2021 brain-health review found enough preclinical signal to justify continued investigation while emphasizing lack of robust human trials [25].
• Additional literature: Separate reviews discuss possible antidepressant mechanisms and neuropharmacologic relevance—but translational rather than definitive clinical story [26].
• Safety: Oxidized linalool hydroperoxides are recognized allergens in dermatitis literature [22].
• Bottom line: Scientifically credible bioactive terpene, but current evidence supports cautious phrasing rather than firm therapeutic promises [22][25][26].

Humulene

• Evidence: Translationally interesting, but early [20][27].
• Scoping-review findings: 2024 review analyzed 340 articles, found broad preclinical evidence for anti-inflammatory and biologic effects, with some rodent work suggesting cannabimimetic properties via CB1 and adenosine A2a pathways [27].
• Interpretation caution: Findings valuable for hypothesis generation, but don’t yet establish consistent human efficacy across pain, inflammation, or mood outcomes [27].
• Bottom line: One of more interesting terpene research targets, but far from clinically settled [27].

Terpinolene

• Evidence: Least clinically characterized terpene in this file [20][28].
• Systematic-review findings: 2021 review screened 2,449 records, included 57 studies, concluding terpinolene has range of reported biological effects but evidence base dominated by in silico, in vitro, and animal studies rather than human trials [28].
• Interpretation caution: Even recent entourage reviews frame terpene benefits as exploratory, not established compound-specific clinical effects [20].
• Bottom line: Biologically interesting, but especially underdeveloped clinically [20][28].

Research limits and interpretation

• Evidence base is highly uneven—CBD and delta-9 THC support most detailed statements; rest require more caution [1]-[29].
• Whole-cannabis extract data, purified-molecule data, semisynthetic cannabinoid data, and terpene-only data are not interchangeable. Common error is letting evidence from one category stand in for another.
• Minor cannabinoids and terpenes are commercially interesting because underexplored—but that means claims often become inflated.
• Product quality matters as much as molecule identity. Labeling inaccuracies, contamination, synthesis byproducts, dose variability, and route-dependent pharmacokinetics all materially affect real-world interpretation [1][10][11][14].
• For THCa, chemistry is destiny: storage and heating can change exposure profile by converting acidic cannabinoids to neutral cannabinoids like THC [12].

Common overstatements to avoid

• Overstatement: CBN is clinically proven sleep cannabinoid.
  More accurate: Specific sleep evidence for CBN remains weak, with no strong validated-trial base identified [16][17].

• Overstatement: Myrcene is proven human sedative explaining couch-lock.
  More accurate: Myrcene has plausible preclinical bioactivity, but direct human proof for that common claim is limited [20][23].

• Overstatement: Terpenes have proven entourage effects in patients.
  More accurate: Entourage hypotheses are influential and worth studying, but robust clinical proof remains limited and highly compound-specific [20][29].

• Overstatement: THCa is always nonpsychoactive.
  More accurate: THCa itself is not THC, but heating and processing can convert THCa to THC, changing effective exposure [12].

• Overstatement: Delta-8 THC is safe because hemp-derived.
  More accurate: Delta-8 THC is psychoactive, pharmacologically close to delta-9 THC, and often entangled with manufacturing and testing concerns [9]-[11].

Practical takeaways for the formulas in this document

• CBD and delta-9 THC have most evidence-developed actives.
• Delta-8 THC is not trivial—psychoactive cannabinoid with less robust safety/efficacy characterization than delta-9 THC.
• THCa meaningfully changes with processing—don’t interpret raw, gently-handled, and heated formats the same way.
• CBG, CBN, CBC are scientifically credible but clinically immature compared to CBD and THC.
• Listed terpenes are likely highly relevant to aroma, flavor, and potentially some biologic activity, but compound-specific human therapeutic claims should be made carefully and only where directly supported.

RSO SUBLINGUAL OIL

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5%
• Format: 30mL bottle
• Active cannabinoids per mL: 553mg

For Clear Creek County residents: This 30mL bottle provides 40-60 doses depending on your needs. At 553mg/mL, it’s among the most concentrated legal hemp products available. The graduated dropper allows precise dosing whether you’re managing acute pain after a mountain bike accident in Floyd Hill or supporting sleep at your cabin near Saint Mary’s Glacier.

RSO VAPE CARTRIDGE

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%
• Format: 1 Gram cartridge
• 510-thread: Universal battery compatibility

For Clear Creek County residents: The vape format offers immediate relief for breakthrough symptoms—whether that’s sudden nerve pain on a cold morning in Empire or acute anxiety before driving Loveland Pass. The 1-2 minute onset is unmatched by any oral product.

TERPENE PROFILE (BOTH PRODUCTS)

Our seven-terpene profile is identical across both formats:

• Limonene (citrus-bright)
• Myrcene
• Caryophyllene (β-caryophyllene—pepper/spice, CB2 agonist)
• Pinene (forest-fresh)
• Linalool (floral, lavender)
• Humulene (earthy, woody)
• Terpinolene (piney, fruity, sparkling)

For Clear Creek County residents: These terpenes create an aromatic profile reminiscent of Colorado’s own landscape—pine forests, citrus brightness from high-altitude sunshine, earthy undertones from mountain soil. The sensory experience connects to the land while the pharmacology works through multiple receptor systems.

FINAL THOUGHTS FOR CLEAR CREEK COUNTY

From Georgetown’s historic downtown to the remote stretches near Berthoud Pass, Clear Creek County residents face unique health challenges: limited local healthcare infrastructure, chronic pain from mountain living, veteran PTSD in rural settings, and cancer treatment requiring travel to Denver. Our RSO formulas were developed not in a corporate boardroom but through a decade of caring for Bentley—a beloved companion—and through Colin’s personal journey overcoming PTSD and benzodiazepine addiction with cannabinoids.

The seven-cannabinoid, seven-terpene formulation reflects real-world necessity: single compounds weren’t enough for Bentley’s complex age-related conditions, just as single-cannabinoid products often fall short for humans managing multiple symptoms. Our open-source transparency means you can verify every claim, while our third-party lab testing ensures what you see is what you get.

Our media record with ABC13 Houston—seven features over four years, documented community action, and personal conviction history—provides third-party validation you can verify independently. We’re not asking you to trust marketing; we’re showing you earned recognition that can’t be purchased.

Whether you choose our professionally manufactured RSO with delivery to your Clear Creek County door, or use our published formula to make your own, the goal is the same: give you the best possible version so you can give it a fair shot and decide if it’s right or you.

As Colin said in that first 2019 interview: we’re not trying to sell snake oil or false hope. We’re providing complete information because you deserve to make an informed decision about your health. In Clear Creek County’s mountain communities, where self-reliance and informed decision-making are core values, that approach feels like home.

Contact us at (832) 416-2816 or [email protected]. Visit our Houston dispensary at 810 Richmond Avenue, or order online at https://oilwellcbd.com/ for delivery to Clear Creek County.

These products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Must be 21+ to purchase. Keep out of reach of children. Consult your healthcare provider before use, especially if pregnant, nursing, or taking medications. Do not operate vehicles or machinery while using psychoactive cannabinoids. Buyer assumes responsibility for compliance with local laws.